Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Perrigo Company PLC (NYSE:PRGO)

96.61
Delayed Data
As of May 27
 +0.41 / +0.43%
Today’s Change
84.85
Today|||52-Week Range
198.42
-33.23%
Year-to-Date
PRGO Regular Dividend: PRGO began trading ex-dividend on 05/25/16. A $0.145 dividend will be paid to shareholders of record as of 05/27/16.
Valeant 'Received Bid Proposal' From Takeda, TPG
May 27 / TheStreet.com - Paid Partner Content
Examining the Current State of Health Care and Skin Care Stocks
May 23 / GuruFocus News - Paid Partner Content
Valeant Works to Restore Accounting Reputation
May 26 / TheStreet.com - Paid Partner Content
Valeant to Evaluate Sales of Noncore Assets
May 23 / TheStreet.com - Paid Partner Content
Valeant Filing: CEO to Earn $1.5M, More if He Meets Goals
May 25 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close96.20
Today’s open96.78
Day’s range96.19 - 97.89
Volume1,279,261
Average volume (3 months)2,512,534
Market cap$13.8B
Dividend yield0.60%
Data as of 4:02pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-95.67%
Earnings growth (this year)--
Earnings growth (next 5 years)+9.00%
Revenue growth (last year)+36.36%
P/E ratio20.4
Price/Sales3.82
Price/Book1.37

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...+1.83+2.10%
INCYIncyte Corp+2.75+3.36%
MDVNMedivation Inc+0.32+0.53%
JAZZJazz Pharmaceuticals...-0.68-0.45%
Data as of 4:00pm ET, 05/27/2016

Financials

Next reporting dateAugust 31, 2016
EPS forecast (this quarter)$2.12
Annual revenue (last year)$5.5B
Annual profit (last year)$11.2M
Net profit margin0.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President &
Chief Executive Officer
John T. Hendrickson
Chief Financial Officer &
Executive Vice President
Judy L. Brown
Corporate headquarters
Dublin, Dublin

Forecasts

Partner Offers

Search for Jobs